Alterations leading to increased ribonucleotide reductase in cells selected for resistance to deoxynucleosides.
D000818:Animals; D001345:Autoradiography; D002460:Cell Line; D002474:Cell-Free System; D002478:Cells, Cultured / Q000201:enzymology; D002852:Chromatography, Ion Exchange; D002999:Clone Cells; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003839:Deoxyadenosines / Q000494:pharmacology; D003841:Deoxycytidine / Q000494:pharmacology; D003853:Deoxyribonucleosides / Q000494:pharmacology*; D003854:Deoxyribonucleotides / Q000494:pharmacology; D004351:Drug Resistance; D005347:Fibroblasts; D006151:Guanosine / Q000031:analogs & derivatives / Q000494:pharmacology; D051379:Mice; D010770:Phosphotransferases / Q000378:metabolism; D012264:Ribonucleotide Reductases / Q000378:metabolism*; D013936:Thymidine / Q000378:metabolism / Q000494:pharmacology; D013937:Thymidine Kinase / Q000378:metabolism; D014316:Tritium
D003839:Deoxyadenosines; D003853:Deoxyribonucleosides; D003854:Deoxyribonucleotides; D003561:Cytarabine; D003841:Deoxycytidine; D014316:Tritium; D006151:Guanosine; D004247:DNA; D012264:Ribonucleotide Reductases; D010770:Phosphotransferases; D013937:Thymidine Kinase; D013936:Thymidine